Team:USTC CHINA/Notebook/Protocols/ELISA
From 2013.igem.org
(Difference between revisions)
(5 intermediate revisions not shown) | |||
Line 7: | Line 7: | ||
<div class="bar" align="center"> | <div class="bar" align="center"> | ||
<div class="container" align="left"> | <div class="container" align="left"> | ||
- | |||
- | |||
<div id="igemlogo"><a href="https://2013.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2013/2/26/2013ustcigem_IGEM_basic_Logo.png" alt="igem home page" width="50" height="40" /></a></div> | <div id="igemlogo"><a href="https://2013.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2013/2/26/2013ustcigem_IGEM_basic_Logo.png" alt="igem home page" width="50" height="40" /></a></div> | ||
+ | |||
<ul id="nav"> | <ul id="nav"> | ||
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Project</a> | |
- | + | <ul class="subs"> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Overview</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails">Project Details</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Parts">Parts</a></li> | |
- | + | </ul> | |
- | + | </li> | |
- | + | <li class="active"><a href="https://2013.igem.org/Team:USTC_CHINA/Notebook">Notebook</a> | |
- | + | <ul class="subs"> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Timeline">Timeline</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Protocols">Protocols</a></li> | |
- | + | </ul> | |
- | + | </li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/">Modeling</a> | |
- | + | <ul class="subs"> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/KillSwitch">Kill Switch</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/B.SubtilisCulture">B.Subtilis Culture</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/DesignsofImmuneExperiments">Designs of Immune Experiments</a></li> | |
- | + | </ul> | |
- | + | </li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/HumanPractice">Human Practice</a> | |
- | + | <ul class="subs"> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/HumanPractice/Communication" >Communication</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/HumanPractice/Activity">Activity</a></li> | |
- | + | </ul> | |
- | + | </li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team">Team</a> | |
- | + | <ul class="subs"> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team">Members</a></li> | |
- | + | <li><a href="https://igem.org/Team.cgi?year=2013&team_name=USTC_CHINA">Profile</a></li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Attributions">Attributions</a></li> | |
- | + | <li><a href="https://igem.org/2013_Judging_Form?id=1074#iGEM_Medals">Achievements</a></li> | |
- | + | </ul> | |
- | + | </li> | |
- | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Safety">Safety</a></li> | |
- | + | </ul> | |
+ | <div id="tlogo"><img src="https://static.igem.org/mediawiki/2013/f/f8/2013ustc-china_T-VACCINE.png" width="100%" height="123" /> | ||
+ | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="content" align="center"> | <div class="content" align="center"> | ||
<div class="conbar1"> | <div class="conbar1"> | ||
- | <div id="breadcrumb"><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a> > <a href="https://2013.igem.org/Team:USTC_CHINA/Notebook"> | + | <div id="breadcrumb"><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a> > <a href="https://2013.igem.org/Team:USTC_CHINA/Notebook">Notebook</a> > <a href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Protocols">Protocols</a>> <a href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Protocols/ELISA">ELISA</a></div></div> |
<div class="conbar2"> | <div class="conbar2"> | ||
<div class="leftbar" align="left"> | <div class="leftbar" align="left"> | ||
<div class="bassic-bar"> | <div class="bassic-bar"> | ||
<h1>ELISA</h1> | <h1>ELISA</h1> | ||
- | <p> | + | <p> |
- | A. Antigen Coating | + | <span>A. Antigen Coating</span> </br> |
- | 1. Prepare an antigen solution at the appropriate concentration in carbonate-bicarbonate buffer (coating buffer), e.g. human IgG (0.025mg/ml) in coating buffer. | + | 1. Prepare an antigen solution at the appropriate concentration in carbonate-bicarbonate buffer (coating buffer), e.g. human IgG (0.025mg/ml) in coating buffer.</br> |
- | 2. Pipette 0.2 ml of the above solution to each well of the microtiter plate. | + | 2. Pipette 0.2 ml of the above solution to each well of the microtiter plate.</br> |
- | + | 3. Incubate at 37 0C for 30 min. </br> | |
- | 4. Remove the coating solution. Wash three times with PBS-T (0.2 ml/well). | + | 4. Remove the coating solution. Wash three times with PBS-T (0.2 ml/well). </br> |
- | 5. Blocking step: 0.5% BSA-PBS (0.2ml/well) at 370C for 30 min (an additional blocking step may be required to block non-specific binding). | + | 5. Blocking step: 0.5% BSA-PBS (0.2ml/well) at 370C for 30 min (an additional blocking step may be required to block non-specific binding). </br> |
- | B. Primary Antibody Reaction | + | <span>B. Primary Antibody Reaction</span> </br> |
- | 1. Dilute the primary (first) antibodies in PBS-T, e.g. Rabbit-anti-human IgG antiserum (different dilutions of antiserum, 1:400~1:51200). | + | 1. Dilute the primary (first) antibodies in PBS-T, e.g. Rabbit-anti-human IgG antiserum (different dilutions of antiserum, 1:400~1:51200). </br> |
- | 2. Add 0.2 ml of the diluted first antibody to each well. Negative control should be included (No first Ab.). | + | 2. Add 0.2 ml of the diluted first antibody to each well. Negative control should be included (No first Ab.). </br> |
- | 3. Incubate at 37 0C for 1 hour. | + | 3. Incubate at 37 0C for 1 hour. </br> |
- | 4. Wash three times with PBS-T (0.2 ml/well). | + | 4. Wash three times with PBS-T (0.2 ml/well). </br> |
- | C. Application of Secondary Antibody | + | <span>C. Application of Secondary Antibody </span></br> |
- | 1. Dilute the peroxidase conjugated secondary antibody in PBS-T, e.g. | + | 1. Dilute the peroxidase conjugated secondary antibody in PBS-T, e.g. Goat-anti-rabbit IgG-HRP (1:20,000). Add 0.2 ml of this solution to each well. </br> |
- | Goat-anti-rabbit IgG-HRP (1:20,000). Add 0.2 ml of this solution to each well. | + | 2. Incubate at 37 0C for 30 min. </br> |
- | 2. Incubate at 37 0C for 30 min. | + | 3. Wash three times with PBS-T (0.2 ml/well). </br> |
- | 3. Wash three times with PBS-T (0.2 ml/well). | + | <span>D. Substrate Preparation </span></br> |
- | D. Substrate Preparation | + | 1. During the last incubation and immediately before use, dissolve o-Phenylenediamine in Citric acid-sodium hydrogen phosphate buffer, add 30% H2O2 before use. </br> |
- | 1. During the last incubation and immediately before use, dissolve | + | <span>E. Development</span> </br> |
- | o-Phenylenediamine in Citric acid-sodium hydrogen phosphate buffer, add 30% H2O2 before use. | + | 1. Add 0.2 ml of the freshly prepared substrate to each well. </br> |
- | E. Development | + | 2. Orange-yellow color should develop in positive wells after 5 minutes.</br> |
- | 1. Add 0.2 ml of the freshly prepared substrate to each well. | + | 3. Stop reaction with 50 l per well of preferred stopping reagent and read at 490nm in a microplate reader.</br> |
- | 2. Orange-yellow color should develop in positive wells after 5 minutes. | + | </br> |
- | 3. Stop reaction with 50 l per well of preferred stopping reagent and read at 490nm in a microplate reader. | + | <span>REAGENTS </span></br> |
- | REAGENTS | + | 1. Coating buffer (Carbonate-Bicarbonate buffer, pH 9.6) : Na2CO3 0.15g, NaHCO3 0.293g, add H2O to 100ml (pH 9.6).</br> |
- | 1. Coating buffer (Carbonate-Bicarbonate buffer, pH 9.6) : Na2CO3 0.15g, NaHCO3 0.293g, add H2O to 100ml (pH 9.6). | + | 2. Phosphate buffered saline (PBS): NaCl 8g, KCl 0.2g, KH2PO4 0.24g,Na2HPO4. 12 H2O 2.9g, add H2O to 1000ml (pH 7.4).</br> |
- | 2. Phosphate buffered saline (PBS): NaCl 8g, KCl 0.2g, KH2PO4 0.24g,Na2HPO4. 12 H2O 2.9g, add H2O to 1000ml (pH 7.4). | + | 3. Washing buffer (PBS-T): PBS + 0.05% Tween 20.</br> |
- | 3. Washing buffer (PBS-T): PBS + 0.05% Tween 20. | + | 4. First antibody: Rabbit-ani-human IgG antiserum.</br> |
- | 4. First antibody: Rabbit-ani-human IgG antiserum. | + | 5. Peroxidase conjugated secondary antibody: Goat-anti-rabbit IgG-HRP (1:20,000).</br> |
- | 5. Peroxidase conjugated secondary antibody: Goat-anti-rabbit IgG-HRP (1:20,000). | + | 6. Substrate: substrate buffer(fresh):</br> |
- | 6. Substrate: substrate buffer(fresh): | + | 0.1M Citric acid (2.1g/100ml), 6.1ml;</br> |
- | 0.1M Citric acid (2.1g/100ml), 6.1ml; | + | 0.2M Na2HPO4. 12 H2O(7.163g/100ml), 6.4ml;</br> |
- | 0.2M Na2HPO4. 12 H2O(7.163g/100ml), 6.4ml; | + | ddH2O 12.5ml;</br> |
- | dissolve 8mg o-Phenylenediamine | + | dissolve 8mg o-Phenylenediamine;</br> |
- | 7. Stopping reagent: 2M H2SO4 | + | add 40ml of 30% H2O2 before use.</br> |
+ | 7. Stopping reagent: 2M H2SO4</br> | ||
</p></div> | </p></div> | ||
Line 99: | Line 101: | ||
<div class="rightbar"> | <div class="rightbar"> | ||
- | <div class="port-sidebar-border"><h> | + | <div class="port-sidebar-border"><h>Notebook</h></div> |
<div class="clear"></div> | <div class="clear"></div> | ||
- | <div id="t1"><a href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Timeline"> | + | <div id="t1"><a href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Timeline">Timeline</a></div> |
- | <div id="t1"><a class="active" href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Protocols"> | + | <div id="t1"><a class="active" href="https://2013.igem.org/Team:USTC_CHINA/Notebook/Protocols">Protocols</a></div></div> |
</div> | </div> | ||
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> |
Latest revision as of 09:12, 27 September 2013